Insider Transactions in Q1 2023 at Guardant Health, Inc. (GH)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 15
2023
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,703
-18.96%
|
$44,278
$26.78 P/Share
|
Mar 15
2023
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,931
+35.44%
|
-
|
Mar 15
2023
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
8,600
+0.42%
|
$223,600
$26.15 P/Share
|
Mar 15
2023
|
Myrtle S Potter Director |
BUY
Grant, award, or other acquisition
|
Direct |
68
+5.53%
|
-
|
Mar 14
2023
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
84,452
+3.97%
|
$2,195,752
$26.33 P/Share
|
Mar 14
2023
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
8,500
+14.91%
|
$221,000
$26.4 P/Share
|
Mar 14
2023
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
8,500
+0.44%
|
$221,000
$26.4 P/Share
|
Mar 13
2023
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
40,000
+45.51%
|
$1,000,000
$25.41 P/Share
|
Mar 13
2023
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
40,000
+1.05%
|
$1,000,000
$25.41 P/Share
|
Mar 04
2023
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+4.98%
|
-
|
Mar 03
2023
|
Kumud Kalia Chief Information Officer |
SELL
Open market or private sale
|
Direct |
6,500
-83.75%
|
$201,500
$31.92 P/Share
|
Mar 01
2023
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
246
-3.07%
|
$7,134
$29.36 P/Share
|
Mar 01
2023
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
711
+8.16%
|
-
|
Mar 01
2023
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
108
-0.77%
|
$3,132
$29.36 P/Share
|
Mar 01
2023
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
263
+1.83%
|
-
|
Mar 01
2023
|
Amelia Merrill SVP, People |
SELL
Payment of exercise price or tax liability
|
Direct |
65
-0.28%
|
$1,885
$29.36 P/Share
|
Mar 01
2023
|
Amelia Merrill SVP, People |
BUY
Exercise of conversion of derivative security
|
Direct |
157
+0.67%
|
-
|
Feb 15
2023
|
Myrtle S Potter Director |
BUY
Grant, award, or other acquisition
|
Direct |
69
+5.93%
|
-
|
Feb 04
2023
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+5.24%
|
-
|
Jan 15
2023
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,320
-24.58%
|
$39,600
$30.43 P/Share
|
Jan 15
2023
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,309
+38.12%
|
-
|
Jan 15
2023
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+6.22%
|
-
|
Jan 07
2023
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,187
-8.45%
|
$54,675
$25.95 P/Share
|
Jan 07
2023
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,375
+17.2%
|
-
|
Jan 04
2023
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
67
+5.61%
|
-
|